Large MCA Territory Stroke
CT/MRI showing ≥50% MCA territory infarction with developing edema
All Pathways
NeurosurgeryManagement
Malignant MCA Stroke - Decompressive Hemicraniectomy Decision
Malignant MCA Stroke - Decompressive Hemicraniectomy Decision: Large MCA Territory Stroke → Confirm Malignant Features → Patient Age? → Age ≤60 Years → ...
Pathway Overview
16 steps
Algorithm Steps
16 total
01Start 02Action Confirm Malignant Features
Imaging criteria for malignant MCA infarction
- Infarct ≥50% MCA territory on CT/DWI
- Volume >145 mL on DWI (ESCAPE criteria)
- Signs of early edema/sulcal effacement
- Midline shift developing
03Decision Patient Age?
Age stratification affects recommendations
04Action Age ≤60 Years
Strong evidence for benefit (AHA Class IIa, LOE A)
- Pooled analysis: mortality 22% vs 71% (NNT=2)
- mRS ≤4 at 1 year: 75% vs 24%
- mRS ≤3 at 1 year: 43% vs 21%
- DECIMAL, DESTINY, HAMLET trials
05Decision Time from Symptom Onset <48h?
Surgical window based on trial criteria
06Action Within Surgical Window
Proceed with evaluation for surgery
07Decision Clinical Criteria Met?
Assess neurological status
- NIHSS ≥15 (or >20 for dominant hemisphere)
- GCS ≥6 (most trials)
- Decline in consciousness (GCS drop)
- New pupillary changes
08Decision Any Contraindications?
Assess for absolute/relative contraindications
- Pre-stroke mRS ≥2 (functional dependence)
- Terminal illness
- Coagulopathy (correct first)
- Bilateral fixed pupils (controversial)
09Action Goals of Care Discussion
Family/surrogate decision-making
- Explain survival vs disability trade-off
- Most survivors have moderate-severe disability
- Quality of life assessment
- Patient's known wishes if available
- Shared decision-making essential
10Action Proceed to Hemicraniectomy
Decompressive surgery
- Bone flap ≥12 cm diameter
- Duraplasty (dura opened and expanded)
- No hematoma evacuation needed
- Bone flap stored for later cranioplasty
11Action Post-Operative Care
ICU management after hemicraniectomy
- Continue ICP monitoring if needed
- DVT prophylaxis after hemostasis
- Early nutrition
- Cranioplasty typically at 6-12 weeks
12Outcome Surgical Outcome
Expected: reduced mortality, but significant disability likely
13Action Conservative/Medical Management
If surgery not pursued
- ICP management (osmotherapy, positioning)
- Comfort-focused care if appropriate
- ICU monitoring
- May reconsider if condition changes
14Outcome Conservative Outcome
Continue supportive care; high mortality without surgery
- Path rejoins step 13Shared downstream outcome
- Path rejoins step 13Shared downstream outcome
15Warning ⚠️ Beyond 48h Window
Limited evidence beyond 48h
- Trial data limited to <48h
- Consider on case-by-case basis
- May still benefit if herniation imminent
- Discuss with neurosurgery
- Path rejoins step 07Shared downstream outcome
16Action Age >60 Years
DESTINY II showed survival benefit but higher disability
- DESTINY II: survival 43% vs 17%
- mRS ≤4: 38% vs 18% at 6 months
- BUT: most survivors have mRS 4-5
- Goals of care discussion critical
- Path rejoins step 05Shared downstream outcome
Guideline Source
AHA/ASA 2019 Guidelines for Early Management of Acute Ischemic Stroke + DESTINY/DECIMAL/HAMLET Trials Pooled Analysis
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Quality of life outcomes must be discussed with family
- Patients >60 have higher mRS despite survival benefit
- Does not address dominant hemisphere considerations fully
- Posterior circulation strokes excluded
- Requires multidisciplinary discussion
Applicable Regions
USEUGlobal
EU: ESO guidelines compatible, European trials (DESTINY, DECIMAL, HAMLET)
US: AHA/ASA Class IIa recommendation for age <60
Version 1Next review: 2027-01-01
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision?
The Malignant MCA Stroke - Decompressive Hemicraniectomy Decision is a management clinical algorithm for Neurosurgery. It provides a structured decision tree to guide clinical decision-making, based on AHA/ASA 2019 Guidelines for Early Management of Acute Ischemic Stroke + DESTINY/DECIMAL/HAMLET Trials Pooled Analysis.
What guideline is the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision based on?
This algorithm is based on AHA/ASA 2019 Guidelines for Early Management of Acute Ischemic Stroke + DESTINY/DECIMAL/HAMLET Trials Pooled Analysis (DOI: 10.1161/STR.0000000000000211).
What are the limitations of the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision?
Known limitations include: Quality of life outcomes must be discussed with family; Patients >60 have higher mRS despite survival benefit; Does not address dominant hemisphere considerations fully; Posterior circulation strokes excluded; Requires multidisciplinary discussion. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free